7

Nilotinib cardiac toxicity: Should we still be concerned?

Year:
2011
Language:
english
File:
PDF, 91 KB
english, 2011
8

Treatment of metastatic malignant melanoma

Year:
2005
Language:
english
File:
PDF, 311 KB
english, 2005
9

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'

Year:
2007
Language:
english
File:
PDF, 134 KB
english, 2007
11

Myeloproliferative Neoplasms

Year:
2012
Language:
english
File:
PDF, 421 KB
english, 2012
12

Chronic Myelogenous Leukemia for Primary Care Physicians

Year:
2012
Language:
english
File:
PDF, 185 KB
english, 2012
15

A new asparaginase option for ALL

Year:
2012
Language:
english
File:
PDF, 80 KB
english, 2012
24

Initial Therapy in Previously Untreated Patients with Chronic Myelogenous Leukemia in Chronic Phase

Year:
2008
Language:
english
File:
PDF, 77 KB
english, 2008
26

Treatment Strategies in Myelodysplastic Syndromes

Year:
2008
Language:
english
File:
PDF, 264 KB
english, 2008
33

Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms

Year:
2009
Language:
english
File:
PDF, 198 KB
english, 2009
35

Emerging drugs for myelofibrosis

Year:
2012
Language:
english
File:
PDF, 662 KB
english, 2012
43

Granulocyte transfusion

Year:
2006
Language:
english
File:
PDF, 82 KB
english, 2006
50

Dasatinib dose management for the treatment of chronic myeloid leukemia

Year:
2018
Language:
english
File:
PDF, 331 KB
english, 2018